10:22 AM EST - Microbix Biosystems Inc. : Announces the commercial usage of its first recombinant antigen product, the nucleocapsid protein of the SARS-CoV-2 virus (COVID-19), in its quality assessment products and its availability at commercial scale for test manufacturers. Microbix Biosystems Inc.
shares T.MBX are trading unchanged at $0.25.
